Advertisement
Product › Details
SNF472 (Sanifit)
Next higher product group | cardiovascular drug_o | |
Status | 2015-09-08 development existent | |
Organisation | Laboratoris Sanifit S. L. | |
Group | Vifor Pharma (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cardiovascular drug_o
- [1] Pfizer Inc.. (8/3/22). "Press Release: Pfizer to Discontinue Development Program for PF-07265803 for LMNA-Related Dilated Cardiomyopathy". New York, NY....
- [2] Pfizer Inc.. (12/13/21). "Press Release: Pfizer to Acquire Arena Pharmaceuticals". New York, NY & Park City, UT....
- [3] Cytokinetics, Inc.. (12/23/20). "Press Release: Cytokinetics Regains European Rights to Omecamtiv Mecarbil". South San Francisco, CA....
- [4] Cytokinetics, Inc.. (11/23/20). "Press Release: Cytokinetics Regains Rights to Develop and Commercialize Omecamtiv Mecarbil and AMG 594 from Amgen". South San Francisco, CA....
- [5] Bristol-Myers Squibb Company. (11/17/20). "Press Release: Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company’s Leading Cardiovascular Franchise". New York, NY....
- [6] Bristol-Myers Squibb Company. (11/5/20). "Press Release: Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash". New York, NY....
- [7] Novo Nordisk A/S. (6/11/20). "Press Release: Novo Nordisk to Acquire Corvidia Therapeutics and Expand Presence in Cardiovascular Disease". Bagsværd....
- [8] Alnylam Pharmaceuticals, Inc.. (4/13/20). "Press Release: Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to Accelerate the Advancement of RNAi Therapeutics". New York, NY & Cambridge, MA....
- [9] Novartis AG. (1/6/20). "Press Release: Novartis Successfully Completes Acquisition of The Medicines Company, Adding a Potentially First-in-Class, Investigational Cholesterol-lowering Therapy Inclisiran". Basel....
- [10] Novartis AG. (1/6/20). "Press Release: Novartis Completes Tender Offer for All Outstanding Shares of The Medicines Company". Basel....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top